| Quarter | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 448 | 514 | 407 | 453 | 448 | 552 | 380 | 319 | 494 | 519 | 403 | 434 | |
Growth YoY Revenue Growth YoY% | -17.2 | -5.7 | 4.8 | 4.1 | 0.0 | 7.5 | -6.5 | -29.7 | 10.4 | -6.0 | 5.9 | 36.3 |
| 383 | 420 | 349 | 378 | 376 | 429 | 355 | 311 | 412 | 414 | 366 | 389 | |
| 65 | 94 | 58 | 75 | 72 | 123 | 25 | 7 | 83 | 105 | 37 | 45 | |
OPM OPM% | 14.5 | 18.4 | 14.3 | 16.5 | 16.1 | 22.3 | 6.6 | 2.3 | 16.7 | 20.3 | 9.2 | 10.3 |
| 0 | 1 | 1 | 0 | 4 | 1 | 1 | 2 | -35 | -41 | 11 | 2 | |
Interest Expense Interest ExpenseCr | 14 | 15 | 20 | 19 | 19 | 18 | 17 | 15 | 16 | 15 | 15 | 13 |
Depreciation DepreciationCr | 29 | 32 | 32 | 32 | 33 | 38 | 39 | 41 | 41 | 42 | 43 | 42 |
PBT PBTCr | 22 | 47 | 7 | 25 | 24 | 68 | -30 | -47 | -9 | 8 | -10 | -9 |
| 6 | 13 | 2 | 7 | 7 | 18 | -8 | -12 | -3 | -6 | -3 | -2 | |
| 16 | 34 | 5 | 18 | 17 | 50 | -22 | -35 | -6 | 14 | -7 | -6 | |
Growth YoY PAT Growth YoY% | -39.0 | -5.8 | -26.1 | 45.6 | 6.8 | 48.1 | -539.2 | -290.7 | -134.3 | -71.3 | 67.0 | 82.5 |
NPM NPM% | 3.6 | 6.6 | 1.3 | 4.0 | 3.8 | 9.1 | -5.9 | -11.0 | -1.2 | 2.8 | -1.8 | -1.4 |
| 1.3 | 2.8 | 0.4 | 1.5 | 1.4 | 4.1 | -1.8 | -2.8 | -0.5 | 1.2 | -0.6 | -0.5 |
| Quarter | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 448 | 514 | 407 | 453 | 448 | 552 | 380 | 319 | 494 | 519 | 403 | 434 | |
Growth YoY Revenue Growth YoY% | -17.2 | -5.7 | 4.8 | 4.1 | 0.0 | 7.5 | -6.5 | -29.7 | 10.4 | -6.0 | 5.9 | 36.3 |
| 383 | 420 | 349 | 378 | 376 | 429 | 355 | 311 | 412 | 414 | 366 | 389 | |
| 65 | 94 | 58 | 75 | 72 | 123 | 25 | 7 | 83 | 105 | 37 | 45 | |
OPM OPM% | 14.5 | 18.4 | 14.3 | 16.5 | 16.1 | 22.3 | 6.6 | 2.3 | 16.7 | 20.3 | 9.2 | 10.3 |
| 0 | 1 | 1 | 0 | 4 | 1 | 1 | 2 | -35 | -41 | 11 | 2 | |
Interest Expense Interest ExpenseCr | 14 | 15 | 20 | 19 | 19 | 18 | 17 | 15 | 16 | 15 | 15 | 13 |
Depreciation DepreciationCr | 29 | 32 | 32 | 32 | 33 | 38 | 39 | 41 | 41 | 42 | 43 | 42 |
PBT PBTCr | 22 | 47 | 7 | 25 | 24 | 68 | -30 | -47 | -9 | 8 | -10 | -9 |
| 6 | 13 | 2 | 7 | 7 | 18 | -8 | -12 | -3 | -6 | -3 | -2 | |
| 16 | 34 | 5 | 18 | 17 | 50 | -22 | -35 | -6 | 14 | -7 | -6 | |
Growth YoY PAT Growth YoY% | -39.0 | -5.8 | -26.1 | 45.6 | 6.8 | 48.1 | -539.2 | -290.7 | -134.3 | -71.3 | 67.0 | 82.5 |
NPM NPM% | 3.6 | 6.6 | 1.3 | 4.0 | 3.8 | 9.1 | -5.9 | -11.0 | -1.2 | 2.8 | -1.8 | -1.4 |
| 1.3 | 2.8 | 0.4 | 1.5 | 1.4 | 4.1 | -1.8 | -2.8 | -0.5 | 1.2 | -0.6 | -0.5 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue RevenueCr | 926 | 1,014 | 1,296 | 1,590 | 1,507 | 1,720 | 1,943 | 2,023 | 1,785 | 1,860 | 1,713 | 1,851 |
Growth Revenue Growth% | 6.2 | 9.5 | 27.8 | 22.6 | -5.2 | 14.1 | 12.9 | 4.1 | -11.8 | 4.2 | -7.9 | 8.9 |
| 745 | 815 | 1,054 | 1,291 | 1,234 | 1,398 | 1,602 | 1,766 | 1,518 | 1,531 | 1,492 | 1,581 | |
| 181 | 198 | 242 | 298 | 273 | 323 | 341 | 257 | 267 | 328 | 220 | 270 | |
OPM OPM% | 19.5 | 19.6 | 18.6 | 18.8 | 18.1 | 18.8 | 17.5 | 12.7 | 15.0 | 17.7 | 12.9 | 14.6 |
| 2 | -1 | 4 | 2 | -12 | 5 | 5 | 5 | 3 | 5 | -73 | -63 | |
Interest Expense Interest ExpenseCr | 62 | 48 | 49 | 58 | 52 | 36 | 31 | 48 | 56 | 75 | 62 | 58 |
Depreciation DepreciationCr | 67 | 69 | 86 | 93 | 82 | 85 | 96 | 109 | 118 | 134 | 164 | 168 |
PBT PBTCr | 53 | 80 | 111 | 149 | 127 | 206 | 219 | 105 | 96 | 124 | -78 | -19 |
| 12 | 13 | 34 | 46 | 42 | 73 | 58 | 27 | 26 | 33 | -30 | -14 | |
PAT PATCr | 41 | 68 | 77 | 103 | 84 | 133 | 161 | 78 | 70 | 91 | -49 | -5 |
Growth PAT Growth% | 2.0 | 64.4 | 14.1 | 33.5 | -18.1 | 57.7 | 20.6 | -51.2 | -11.2 | 30.5 | -153.7 | -149.5 |
NPM NPM% | 4.5 | 6.7 | 6.0 | 6.5 | 5.6 | 7.7 | 8.3 | 3.9 | 3.9 | 4.9 | -2.9 | -0.3 |
| 3.3 | 5.5 | 6.3 | 8.4 | 6.8 | 10.8 | 13.0 | 6.4 | 5.6 | 7.4 | -4.0 | -0.4 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue RevenueCr | 926 | 1,014 | 1,296 | 1,590 | 1,507 | 1,720 | 1,943 | 2,023 | 1,785 | 1,860 | 1,713 | 1,851 |
Growth Revenue Growth% | 6.2 | 9.5 | 27.8 | 22.6 | -5.2 | 14.1 | 12.9 | 4.1 | -11.8 | 4.2 | -7.9 | 8.9 |
| 745 | 815 | 1,054 | 1,291 | 1,234 | 1,398 | 1,602 | 1,766 | 1,518 | 1,531 | 1,492 | 1,581 | |
| 181 | 198 | 242 | 298 | 273 | 323 | 341 | 257 | 267 | 328 | 220 | 270 | |
OPM OPM% | 19.5 | 19.6 | 18.6 | 18.8 | 18.1 | 18.8 | 17.5 | 12.7 | 15.0 | 17.7 | 12.9 | 14.6 |
| 2 | -1 | 4 | 2 | -12 | 5 | 5 | 5 | 3 | 5 | -73 | -63 | |
Interest Expense Interest ExpenseCr | 62 | 48 | 49 | 58 | 52 | 36 | 31 | 48 | 56 | 75 | 62 | 58 |
Depreciation DepreciationCr | 67 | 69 | 86 | 93 | 82 | 85 | 96 | 109 | 118 | 134 | 164 | 168 |
PBT PBTCr | 53 | 80 | 111 | 149 | 127 | 206 | 219 | 105 | 96 | 124 | -78 | -19 |
| 12 | 13 | 34 | 46 | 42 | 73 | 58 | 27 | 26 | 33 | -30 | -14 | |
PAT PATCr | 41 | 68 | 77 | 103 | 84 | 133 | 161 | 78 | 70 | 91 | -49 | -5 |
Growth PAT Growth% | 2.0 | 64.4 | 14.1 | 33.5 | -18.1 | 57.7 | 20.6 | -51.2 | -11.2 | 30.5 | -153.7 | -149.5 |
NPM NPM% | 4.5 | 6.7 | 6.0 | 6.5 | 5.6 | 7.7 | 8.3 | 3.9 | 3.9 | 4.9 | -2.9 | -0.3 |
| 3.3 | 5.5 | 6.3 | 8.4 | 6.8 | 10.8 | 13.0 | 6.4 | 5.6 | 7.4 | -4.0 | -0.4 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital Equity CapitalCr | 16 | 16 | 16 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 |
Reserves ReservesCr | 547 | 589 | 653 | 732 | 792 | 909 | 1,043 | 1,109 | 1,163 | 1,238 | 1,174 | 1,157 |
| 374 | 440 | 560 | 603 | 596 | 657 | 769 | 662 | 757 | 790 | 679 | 737 | |
| 337 | 334 | 312 | 327 | 355 | 323 | 376 | 590 | 543 | 477 | 488 | 423 | |
| 1,275 | 1,379 | 1,542 | 1,686 | 1,768 | 1,913 | 2,213 | 2,385 | 2,487 | 2,529 | 2,365 | 2,341 | |
| 467 | 577 | 690 | 830 | 775 | 879 | 964 | 939 | 967 | 995 | 884 | 870 | |
| 808 | 803 | 852 | 855 | 993 | 1,035 | 1,249 | 1,446 | 1,521 | 1,534 | 1,481 | 1,471 | |
| 1,275 | 1,379 | 1,542 | 1,686 | 1,768 | 1,913 | 2,213 | 2,385 | 2,487 | 2,529 | 2,365 | 2,341 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital Equity CapitalCr | 16 | 16 | 16 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 |
Reserves ReservesCr | 547 | 589 | 653 | 732 | 792 | 909 | 1,043 | 1,109 | 1,163 | 1,238 | 1,174 | 1,157 |
| 374 | 440 | 560 | 603 | 596 | 657 | 769 | 662 | 757 | 790 | 679 | 737 | |
| 337 | 334 | 312 | 327 | 355 | 323 | 376 | 590 | 543 | 477 | 488 | 423 | |
| 1,275 | 1,379 | 1,542 | 1,686 | 1,768 | 1,913 | 2,213 | 2,385 | 2,487 | 2,529 | 2,365 | 2,341 | |
| 467 | 577 | 690 | 830 | 775 | 879 | 964 | 939 | 967 | 995 | 884 | 870 | |
| 808 | 803 | 852 | 855 | 993 | 1,035 | 1,249 | 1,446 | 1,521 | 1,534 | 1,481 | 1,471 | |
| 1,275 | 1,379 | 1,542 | 1,686 | 1,768 | 1,913 | 2,213 | 2,385 | 2,487 | 2,529 | 2,365 | 2,341 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 186 | 163 | 139 | 186 | 285 | 229 | 294 | 315 | 187 | 280 | 302 | |
| -64 | -102 | -110 | -125 | -164 | -156 | -284 | -292 | -174 | -137 | -145 | |
| -124 | -63 | -25 | -55 | -101 | -97 | -6 | -8 | -27 | -144 | -160 | |
Net Cash Flow Net Cash FlowCr | -2 | -2 | 4 | 6 | 20 | -24 | 4 | 15 | -14 | 0 | -3 |
Free Cash Flow Free Cash FlowCr | 127 | 58 | 33 | 57 | 127 | 71 | 21 | 13 | -17 | 144 | 154 |
CFO To PAT CFO To PAT% | 450.5 | 241.4 | 179.8 | 180.1 | 337.4 | 172.0 | 183.0 | 402.3 | 268.3 | 308.8 | -618.9 |
CFO To EBITDA CFO To EBITDA% | 102.6 | 82.4 | 57.4 | 62.3 | 104.3 | 70.9 | 86.3 | 122.7 | 69.9 | 85.4 | 137.0 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 186 | 163 | 139 | 186 | 285 | 229 | 294 | 315 | 187 | 280 | 302 | |
| -64 | -102 | -110 | -125 | -164 | -156 | -284 | -292 | -174 | -137 | -145 | |
| -124 | -63 | -25 | -55 | -101 | -97 | -6 | -8 | -27 | -144 | -160 | |
Net Cash Flow Net Cash FlowCr | -2 | -2 | 4 | 6 | 20 | -24 | 4 | 15 | -14 | 0 | -3 |
Free Cash Flow Free Cash FlowCr | 127 | 58 | 33 | 57 | 127 | 71 | 21 | 13 | -17 | 144 | 154 |
CFO To PAT CFO To PAT% | 450.5 | 241.4 | 179.8 | 180.1 | 337.4 | 172.0 | 183.0 | 402.3 | 268.3 | 308.8 | -618.9 |
CFO To EBITDA CFO To EBITDA% | 102.6 | 82.4 | 57.4 | 62.3 | 104.3 | 70.9 | 86.3 | 122.7 | 69.9 | 85.4 | 137.0 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 963 | 1,749 | 1,689 | 2,157 | 863 | 1,769 | 4,962 | 3,476 | 3,265 | 4,933 | 1,813 | 2,722 |
Price To Earnings Price To Earnings | 24.4 | 25.8 | 21.9 | 20.9 | 10.2 | 13.3 | 30.9 | 44.3 | 47.0 | 54.4 | ||
Price To Sales Price To Sales | 1.0 | 1.7 | 1.3 | 1.4 | 0.6 | 1.0 | 2.5 | 1.7 | 1.8 | 2.6 | 1.1 | 1.5 |
Price To Book Price To Book | 2.1 | 2.9 | 2.5 | 2.9 | 1.1 | 1.9 | 4.7 | 3.1 | 2.8 | 3.9 | 1.5 | 2.3 |
EV To EBITDA EV To EBITDA | 7.8 | 11.5 | 9.3 | 9.1 | 5.0 | 7.0 | 16.4 | 16.2 | 15.2 | 17.3 | 11.3 | 12.4 |
GPM GPM% | 37.2 | 37.1 | 33.4 | 33.2 | 33.6 | 33.3 | 34.0 | 30.3 | 36.6 | 38.3 | 37.9 | 37.9 |
OPM OPM% | 19.5 | 19.6 | 18.6 | 18.8 | 18.1 | 18.8 | 17.5 | 12.7 | 15.0 | 17.7 | 12.9 | 14.6 |
NPM NPM% | 4.5 | 6.7 | 6.0 | 6.5 | 5.6 | 7.7 | 8.3 | 3.9 | 3.9 | 4.9 | -2.9 | -0.3 |
ROCE ROCE% | 11.2 | 11.1 | 12.9 | 15.3 | 13.0 | 16.8 | 14.3 | 8.2 | 7.6 | 9.8 | -0.9 | 2.1 |
ROE ROE% | 7.3 | 11.2 | 11.5 | 13.6 | 10.3 | 14.3 | 15.0 | 6.9 | 5.9 | 7.2 | -4.1 | -0.4 |
ROA ROA% | 3.2 | 4.9 | 5.0 | 6.1 | 4.8 | 7.0 | 7.3 | 3.3 | 2.8 | 3.6 | -2.1 | -0.2 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 963 | 1,749 | 1,689 | 2,157 | 863 | 1,769 | 4,962 | 3,476 | 3,265 | 4,933 | 1,813 | 2,722 |
Price To Earnings Price To Earnings | 24.4 | 25.8 | 21.9 | 20.9 | 10.2 | 13.3 | 30.9 | 44.3 | 47.0 | 54.4 | ||
Price To Sales Price To Sales | 1.0 | 1.7 | 1.3 | 1.4 | 0.6 | 1.0 | 2.5 | 1.7 | 1.8 | 2.6 | 1.1 | 1.5 |
Price To Book Price To Book | 2.1 | 2.9 | 2.5 | 2.9 | 1.1 | 1.9 | 4.7 | 3.1 | 2.8 | 3.9 | 1.5 | 2.3 |
EV To EBITDA EV To EBITDA | 7.8 | 11.5 | 9.3 | 9.1 | 5.0 | 7.0 | 16.4 | 16.2 | 15.2 | 17.3 | 11.3 | 12.4 |
GPM GPM% | 37.2 | 37.1 | 33.4 | 33.2 | 33.6 | 33.3 | 34.0 | 30.3 | 36.6 | 38.3 | 37.9 | 37.9 |
OPM OPM% | 19.5 | 19.6 | 18.6 | 18.8 | 18.1 | 18.8 | 17.5 | 12.7 | 15.0 | 17.7 | 12.9 | 14.6 |
NPM NPM% | 4.5 | 6.7 | 6.0 | 6.5 | 5.6 | 7.7 | 8.3 | 3.9 | 3.9 | 4.9 | -2.9 | -0.3 |
ROCE ROCE% | 11.2 | 11.1 | 12.9 | 15.3 | 13.0 | 16.8 | 14.3 | 8.2 | 7.6 | 9.8 | -0.9 | 2.1 |
ROE ROE% | 7.3 | 11.2 | 11.5 | 13.6 | 10.3 | 14.3 | 15.0 | 6.9 | 5.9 | 7.2 | -4.1 | -0.4 |
ROA ROA% | 3.2 | 4.9 | 5.0 | 6.1 | 4.8 | 7.0 | 7.3 | 3.3 | 2.8 | 3.6 | -2.1 | -0.2 |
| Market CapitalizationMkt CapCr | 18,234 | 9,797 | 5,595 | 2,722 | 1,984 | 1,812 | 230 |
| Close PriceClose₹ | 451.70 | 517.60 | 977.80 | 220.76 | 961.25 | 115.57 | 207.00 |
| IndustryIndustry | Pharma CRAMS | Pharma CRAMS | Pharma CRAMS | Pharma CRAMS | Pharma CRAMS | Pharma CRAMS | Pharma CRAMS |
| Price To EarningsPE | 97.56 | 32.35 | 33.56 | 30.41 | 17.54 | ||
| Price To SalesPS | 5.18 | 8.94 | 3.00 | 1.47 | 2.19 | 0.66 | 2.28 |
| RevenueRevenueCr | 3,522 | 1,096 | 1,865 | 1,851 | 904 | 2,756 | 101 |
| Revenue Growth TTMRev Gr TTM% | -6.0% | -7.0% | 36.8% | 8.9% | 19.0% | -0.1% | 22.3% |
| PAT Growth TTMPAT Gr TTM% | -60.3% | -19.0% | 34.0% | -149.5% | 8.9% | -184.9% | 44.5% |
| Market CapitalizationMkt CapCr | 18,234 | 9,797 | 5,595 | 2,722 | 1,984 | 1,812 | 230 |
| Close PriceClose₹ | 451.70 | 517.60 | 977.80 | 220.76 | 961.25 | 115.57 | 207.00 |
| IndustryIndustry | Pharma CRAMS | Pharma CRAMS | Pharma CRAMS | Pharma CRAMS | Pharma CRAMS | Pharma CRAMS | Pharma CRAMS |
| Price To EarningsPE | 97.56 | 32.35 | 33.56 | 30.41 | 17.54 | ||
| Price To SalesPS | 5.18 | 8.94 | 3.00 | 1.47 | 2.19 | 0.66 | 2.28 |
| RevenueRevenueCr | 3,522 | 1,096 | 1,865 | 1,851 | 904 | 2,756 | 101 |
| Revenue Growth TTMRev Gr TTM% | -6.0% | -7.0% | 36.8% | 8.9% | 19.0% | -0.1% | 22.3% |
| PAT Growth TTMPAT Gr TTM% | -60.3% | -19.0% | 34.0% | -149.5% | 8.9% | -184.9% | 44.5% |